EP3402878A1 - Neuartige impfstoffzusammensetzungen mit kreuzschutz für das porzine epidemische diarrhoevirus - Google Patents

Neuartige impfstoffzusammensetzungen mit kreuzschutz für das porzine epidemische diarrhoevirus

Info

Publication number
EP3402878A1
EP3402878A1 EP16704501.2A EP16704501A EP3402878A1 EP 3402878 A1 EP3402878 A1 EP 3402878A1 EP 16704501 A EP16704501 A EP 16704501A EP 3402878 A1 EP3402878 A1 EP 3402878A1
Authority
EP
European Patent Office
Prior art keywords
pedv
seq
virus
vaccine composition
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16704501.2A
Other languages
English (en)
French (fr)
Inventor
Marta Cabana Sumsi
Monica Balasch Sanuy
Laia PLAJA DILMÉ
Alicia Urniza Hostench
Paul J. Dominowski
Jay Gregory Calvert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zoetis Services LLC
Original Assignee
Zoetis Services LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services LLC filed Critical Zoetis Services LLC
Publication of EP3402878A1 publication Critical patent/EP3402878A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20061—Methods of inactivation or attenuation
    • C12N2770/20064—Methods of inactivation or attenuation by serial passage

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP16704501.2A 2016-01-11 2016-01-11 Neuartige impfstoffzusammensetzungen mit kreuzschutz für das porzine epidemische diarrhoevirus Withdrawn EP3402878A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/012899 WO2017123201A1 (en) 2016-01-11 2016-01-11 Novel cross protective vaccine compositions for porcine epidemic diarrhea virus

Publications (1)

Publication Number Publication Date
EP3402878A1 true EP3402878A1 (de) 2018-11-21

Family

ID=55358111

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16704501.2A Withdrawn EP3402878A1 (de) 2016-01-11 2016-01-11 Neuartige impfstoffzusammensetzungen mit kreuzschutz für das porzine epidemische diarrhoevirus

Country Status (3)

Country Link
EP (1) EP3402878A1 (de)
CA (1) CA3010977A1 (de)
WO (1) WO2017123201A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115074334A (zh) * 2021-03-15 2022-09-20 夏津新希望六和农牧有限公司 猪流行性腹泻病毒株、扩增培养方法、及其制备的疫苗组合物、制备方法和应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108060139B (zh) * 2017-08-31 2021-07-20 浙江美保龙生物技术有限公司 一种猪流行性腹泻病毒的分离培养方法
CN107446894A (zh) * 2017-09-15 2017-12-08 天津瑞普生物技术股份有限公司 一种猪流行性腹泻病毒制备方法
EP3852797A1 (de) * 2018-09-20 2021-07-28 Boehringer Ingelheim Vetmedica GmbH Modifiziertes pedv-spike-protein
CN110894216B (zh) * 2019-11-21 2022-03-08 河北农业大学 一种猪流行性腹泻病毒抗原表位肽、单克隆抗体及应用
CN114438040A (zh) * 2020-11-04 2022-05-06 中山大学 一种分泌具有pedv中和活性抗体的单克隆细胞株及其应用
CN114931648B (zh) * 2022-06-15 2024-02-27 金宇保灵生物药品有限公司 一种猪流行性腹泻和猪传染性胃肠炎二联活疫苗耐热保护剂及其制备方法和应用
CN116445528A (zh) * 2023-04-14 2023-07-18 扬州大学 重组猪流行性腹泻病毒感染性克隆的构建方法及其感染性克隆和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
IL101715A (en) 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
US5769047A (en) 1991-12-23 1998-06-23 Zoche; Michael Engine with oil separator
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
GB9518220D0 (en) 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene
CA2745736C (en) 1996-10-23 2016-11-22 The Trustees Of The University Of Pennsylvania Immunotherapy and improved vaccines
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
BR9908267A (pt) 1998-02-27 2000-10-24 Univ Pennsylvania Plasmìdeo, composição farmacêutica, processos para induzir uma resposta imunológica em um indivìduo contra um imunógeno, para imunizar um indivìduo contra uma infecção por vìrus de herpes simples e para tratar um indivìduo que tem uma doença autoimune, vacina recombinante, e, patógeno atenuado vivo
DE69937571T2 (de) 1998-09-30 2008-09-04 The Government Of The United States Of America As Represented By The Uniformed Services University Of The Health Sciences Mutiertes cholera holotoxin als hilfsmittel
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
AU2002346249B2 (en) 2001-06-07 2007-03-15 The Regents Of The University Of Colorado Mutant Forms of Cholera Holotoxin as an Adjuvant
IL159209A0 (en) 2001-06-07 2004-06-01 Wyeth Corp Mutant forms of cholera holotoxin as an adjuvant
CA2496750C (en) 2002-08-26 2014-10-21 Pfizer Products Inc. Vaccine for respiratory and reproductive system infections in cattle
KR100502008B1 (ko) 2003-04-29 2005-07-18 녹십자수의약품(주) 약독화된 돼지 유행성설사병 바이러스, 그를 포함하는면역원성 조성물 및 상기 바이러스를 검출하는 방법
DK2310046T3 (da) 2008-06-27 2016-04-25 Zoetis Services Llc Hidtil ukendte adjuvanssammensætninger
CN104152578B (zh) * 2013-06-03 2016-03-30 中国农业科学院上海兽医研究所 猪流行性腹泻病毒rt-pcr鉴别诊断试剂盒及其应用
CA3005608C (en) 2013-09-19 2020-06-30 Zoetis Services Llc Water-in-oil emulsions comprising immunostimulatory oligonucleotides
PT3166634T (pt) * 2014-07-11 2021-09-29 Zoetis Services Llc Composições de vacina inovadoras para vírus da diarreia epidémica suína

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115074334A (zh) * 2021-03-15 2022-09-20 夏津新希望六和农牧有限公司 猪流行性腹泻病毒株、扩增培养方法、及其制备的疫苗组合物、制备方法和应用
CN115074334B (zh) * 2021-03-15 2024-01-19 夏津新希望六和农牧有限公司 猪流行性腹泻病毒株、扩增培养方法、及其制备的疫苗组合物、制备方法和应用

Also Published As

Publication number Publication date
CA3010977A1 (en) 2017-07-20
WO2017123201A1 (en) 2017-07-20

Similar Documents

Publication Publication Date Title
US10953088B2 (en) Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
EP3402878A1 (de) Neuartige impfstoffzusammensetzungen mit kreuzschutz für das porzine epidemische diarrhoevirus
TWI602575B (zh) 豬肺炎黴漿菌疫苗
ES2719483T3 (es) Vacuna de combinación CVP/Mycoplasma hyopneumoniae/SRRP
CN113454102A (zh) 非洲猪瘟疫苗
RU2442603C2 (ru) Вакцина против вируса синего языка и иммуногенные композиции, способы их применения и способы их получения
AU2022231761A1 (en) Mycoplasma bovis compositions
US9872897B2 (en) Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof
TWI306404B (en) Method of vaccination against testicular bvdv infection
US11124777B2 (en) Attenuated porcine sapelovirus strain and immunogenic compositions therefrom
CN115322972B (zh) 一株h9亚型禽流感病毒分离株及其应用
JP2023520803A (ja) 口蹄疫ウイルス様粒子抗原、及びそのワクチン組成物、調製方法と使用
US20220249650A1 (en) Senecavirus a virus strains and immunogenic compositions therefrom
KR101345786B1 (ko) 신규한 돼지생식기호흡기증후군 바이러스 및 그의 용도
WO2022072431A1 (en) Novel pasteurella multocida strains and vaccines having hyac and nanp deletions

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180709

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20190725

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20191205